| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/TRF.14010 |
| P698 | PubMed publication ID | 28191640 |
| P2093 | author name string | Albrecht Gröner | |
| Nathan J Roth | |||
| Thomas Nowak | |||
| Birgit Popp | |||
| Wolfram Schäfer | |||
| Uwe Kalina | |||
| Karlheinz Enssle | |||
| P2860 | cites work | Eight prion strains have PrP(Sc) molecules with different conformations | Q29617277 |
| Prion removal capacity of plasma protein manufacturing processes: a data collection from PPTA member companies | Q30582294 | ||
| Long-term safety and efficacy of a pasteurized nanofiltrated prothrombin complex concentrate (Beriplex P/N): a pharmacovigilance study | Q33405392 | ||
| Clinical review: Prothrombin complex concentrates--evaluation of safety and thrombogenicity | Q35567088 | ||
| Pathogen safety of human C1 esterase inhibitor concentrate | Q39380695 | ||
| Molecular mechanism underlying B19 virus inactivation and comparison to other parvoviruses | Q40078515 | ||
| Impact of infusion speed on the safety and effectiveness of prothrombin complex concentrate: a prospective clinical trial of emergency anticoagulation reversal | Q43269909 | ||
| Investigations of prion and virus safety of a new liquid IVIG product. | Q45396536 | ||
| Identification of prothrombin as a major thrombogenic agent in prothrombin complex concentrates | Q45876129 | ||
| Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trial. | Q49155525 | ||
| Prion removal by nanofiltration under different experimental conditions. | Q51794536 | ||
| Inactivation of parvovirus B19 during pasteurization of human serum albumin. | Q53955493 | ||
| P433 | issue | 5 | |
| P921 | main subject | prothrombin complex concentrate | Q2044524 |
| P304 | page(s) | 1184-1191 | |
| P577 | publication date | 2017-02-12 | |
| P1433 | published in | Transfusion | Q15758500 |
| P1476 | title | Pathogen safety of a pasteurized four-factor human prothrombin complex concentrate preparation using serial 20N virus filtration | |
| P478 | volume | 57 |
| Q91944141 | Polysaccharide-based chromatographic adsorbents for virus purification and viral clearance | cites work | P2860 |
Search more.